We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Hookipa Biotech

News List

Hookipa Biotech Initiates First-in-Human Study of Cytomegalovirus Vaccine b3cnewswire
September 30, 2018
Hookipa Biotech AG, a company pioneering a new class of immunotherapies and vaccines, based on its proprietary viral vector platform Vaxwave®, today announces the start of a first-in-human study to evaluate the safety and immunogenicity of its vaccine can
Hookipa Biotech raises $60 million in Round C Financing biospectrumasia
December 13, 2017
All current Hookipa investors, Sofinnova Partners, Forbion Capital Partners, Boehringer Ingelheim Venture Fund, Takeda Ventures and BioMedPartners participated in the round
Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech b3cnewswire
April 20, 2017
Hookipa Biotech AG, a company pioneering a new class of immunotherapies for oncology and infectious diseases, today announces that Reinhard Kandera has joined the Company as Chief Financial Officer (CFO).